NIKKEI 225
29,068.63 +517.70 (+1.81%) HANG SENG
25,330.96 +368.37 (+1.48%) CRUDE OIL
82.66 +1.35 (+1.66%) GOLD FUTURES
1,768.10 -29.80 (-1.66%) DOW
35,294.76 +382.20 (+1.09%) BTC-GBP
45,154.47 +510.55 (+1.14%)
Gilead Sciences, Inc. (GILD)
| Previous close | 68.15 |
| Open | 68.30 |
| Bid | 67.55 x 1000 |
| Ask | 67.64 x 1400 |
| Day's range | 67.61 - 68.60 |
| 52-week range | 56.56 - 73.34 |
| Volume | 4,117,440 |
| Avg. volume | 6,237,171 |
| Market cap | 84.795B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 16.56 |
| EPS (TTM) | 4.09 |
| Earnings date | 28 Oct 2021 |
| Forward dividend & yield | 2.84 (4.20%) |
| Ex-dividend date | 14 Sept 2021 |
| 1y target est | 76.03 |
- Yahoo Finance Video
NIH Director on FDA ‘being careful’ in clearing Moderna vaccine for kids 12-17
Dr. Francis Collins, Outgoing NIH Director, joins Yahoo Finance’s Anjalee Khemlani to discuss Covid-19 vaccine production, drug development research, and misinformation surrounding Covid-19 vaccines.
- Business Wire
Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for Adult Patients With Metastatic Triple-Negative Breast Cancer
FOSTER CITY, Calif., October 15, 2021--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for sacituzumab govitecan as monotherapy indicated for adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for advanced disease. The final European Commission decision on
- Business Wire
Gilead Sciences to Release Third Quarter 2021 Financial Results on Thursday, October 28, 2021
FOSTER CITY, Calif., October 14, 2021--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2021 financial results will be released on Thursday, October 28, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s third quarter 2021 financial results and will provide a business update.
